Showing results (11-20 of 990) with videos related to
Sort By:
Pageof 99
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147Amanda I Phipps, Qian Shi, Polly A Newcomb, et al.Journal of the National Cancer Institute|July 11, 2015
Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer PatientsHarry H Yoon, Qian Shi, Steven R Alberts, et al.Chinese Clinical Oncology|November 22, 2014
Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicineSumithra J Mandrekar, Daniel J SargentClinical Trials (London, England)|April 16, 2010
Predictive biomarker validation in practice: lessons from real trialsSumithra J Mandrekar, Daniel J SargentGenome Medicine|July 30, 2009
Genomic advances and their impact on clinical trial designSumithra J Mandrekar, Daniel J SargentCurrent Opinion in Oncology|May 16, 2009
Clinical implications of microsatellite instability in sporadic colon cancersFrank A Sinicrope, Daniel J SargentClinical Trials (London, England)|August 29, 2013
Statistical issues in the validation of prognostic, predictive, and surrogate biomarkersDaniel J Sargent, Sumithra J MandrekarJournal of Biopharmaceutical Statistics|April 5, 2014
Randomized phase II clinical trialsSin-Ho Jung, Daniel J SargentClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2012
Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implicationsFrank A Sinicrope, Daniel J SargentJournal of Biopharmaceutical Statistics|December 7, 2006
Duffy-Santner confidence intervals for the two-stage three-outcome designAlfred F Furth, Daniel J SargentPageof 99